Elon Musk has unusual plans for neuralinks brain-computer interfaces that give people.Superpower” To Download Your memories. The Spanish competition of the neuroelectronics of the Inbrain has a simpler goal: improvement of our health – and nothing more.
“I know that Elon Musk wants to use Neuralink to drive a Tesla or the like, but we will never go beyond therapeutic applications,” Carolina Aguilar, CEO and co -founder of Inbrain, told TNW.
While Musk has headlines with futuristic ambitions for improving human times, the Inbrain has constantly focused on developing its neuronal interfaces to treat neurological diseases. The company's technology also differs. It is built on the Graph “Miracle Material”.
Graphen is an ultra-thin, strong, flexible material that directs electricity without dismantling. It has the potential to be more effective and less invasive than the metals and polymers used by companies such as Neuralink, Blackrock Neurotech or Medtronic in brain computer interfaces.
The 💜 the EU technology
The latest rumors from the EU -Tech scene, a story of our wise old founder Boris and some questionable KI art. It is free of charge every week in your inbox. Register now!
Inbrain's device consists of tiny graphic electrodes on a film that is thinner than human hair. The implant reads electrical signals from the brain and returns electrical impulses if necessary. It was developed to treat neurological disorders by aiming at the basic cause: faulty brain signals.
Inbrain's first focus is on Parkinson's disease. The implant based in the graph base is designed in such a way that certain neuronal signals that are bound to the motor function only provide ultra-specific stimulation if necessary. “It won't heal the disease, but it will heal the symptoms of it” Aguilar.
From the laboratory to the human brain
Last year, the Inbrain carried out the world's first in-Human attempt with its based implant at the University of Manchester.
The surgeons temporarily put the device on the brain of a patient during the tumor surgery. In just 79 minutes it identified a healthy and cancer -like fabric with micrometer precision. Inbrain is now planning to test the device in up to 10 patients in order to evaluate the safety of graphs in the brain as part of the EU 1 billion € Graphen flagship Project.
Afterwards, Inbrain aims to start clinical studies of his therapeutic implant for Parkinson's disease, said Aguilar.
This system combines two components: a thin, cellophan -like leaf that rests on the surface of the brain to read electrical activity, and a second, deeper implant, which delivers highly targeted stimulation for areas that control the movement.
“With artificial intelligence, the device can learn from the brain of every patient to carry out personalized neurological therapy,” said Aguilar.
But that's just the beginning. Inbrain hopes to use the same system with a closed circuit to tackle diseases such as epilepsy, dementia and chronic pain. Ultimately, it could help to restore lost functions such as language or exercise in patients with neurological damage.
Inbrain was founded in 2020 and has so far collected $ 100 million Aguilar. This includes a 50 million. -Dollar series -b round that was closed last year and a grant of $ 4.5 million from the Spanish Ministry of Industry and Tourism, announced last week. When asked about the future financing outlook of the company, Aguilar stated that an IPO was an option.
“We want to have the greatest effect as soon as possible, and if the best route is opened to get there, let's take it,” she said.
Aguilar also said that she would have been open to the “right partner”, but added that she was not sure whether Neuralink “fits well”.
The future of the tech is a central theme of the TNW conference, which takes place in Amsterdam on June 19th to 20th. Tickets for the event are now on sale – Use the code TNWXMedia2025 at the cash register to get 30%.
Comments are closed.